1st Value Added Medicines Conference – a New Value Proposition for Patients, Healthcare Practitioners and Systems


22 Nov 2017


Renaissance Brussels Hotel
Rue du Parnasse 19
1050  Brussels


Health & Consumers

Event Location


Event Description

Many stakeholders believe innovation only leads to generating new molecules, but innovation can also come from other areas such as focusing on improving present molecules which are no longer protected by patent.
There is significant untapped potential in Europe to optimise existing therapies and value added medicines represent an opportunity for patients, healthcare providers, payers, industry and the healthcare systems in general.
Come and join us for the first Value Added Medicines Conference in Brussels to learn more about value added medicines and to discuss the current environment, challenges and opportunities in Europe.
Keynote Speeches
  • Tackling wasteful spending on health
Main topics
  • Incremental innovation on known molecules – Necessity to address all patient needs?
  • Value added medicines – How to capture their value for society
The target audience is policy makers, industry, academics and other stakeholders involved.
The discussion will be on repurposing medicines.
More information and link to registration can be found here.


OSCE Office for Democratic Institutions and Human Rights
Associate Officer
European Transport Workers' Federation
Political Assistant
European Transport Workers' Federation
Financial Manager
European Transport Workers' Federation
European Energy Forum
Events & Communications Intern
Victim Support Europe
Finance Officer
Global Partnership for the Prevention of Armed Conflict
Policy and Advocacy Internship (Gender team)
Global Partnership for the Prevention of Armed Conflict
Policy & Advocacy Intern
Global Partnership for the Prevention of Armed Conflict
Content Editor Intern